Mattias Hofmans
- ORCID iD
- 0000-0003-2061-7617
Show
Sort by
-
- Journal Article
- A1
- open access
Flow cytometry interference in patients treated with tafasitamab : unraveling the diagnostic maze
-
The added value of automated HPC count : detecting clinically important interferences on the flow cytometric CD34+cell count
-
- Journal Article
- A1
- open access
In-depth blood immune profiling of Good syndrome patients
-
Systemic mastocytosis with myeloid sarcoma and B-CLL : molecular and clonal heterogeneity in a rare case of SM-AHN
-
The clinical spectrum and biological findings in RAS-associated juvenile myelomonocytic leukemia and RAS-associated autoimmune leukoproliferative disorder
-
Systemic mastocytosis with myeloid sarcoma and B-CLL : molecular and clonal heterogeneity in a rare case of SM-AHN with review of literature
-
- Journal Article
- A1
- open access
Immunophenotypic analysis of acute megakaryoblastic leukemia : a EuroFlow study
-
Mutational permutations of a single amino acid exert divergent phenotypic effects in human, mice and cellular models of SAMD9L bone marrow failure disorder
-
- Journal Article
- A1
- open access
The Euroflow PID Orientation Tube in the diagnostic workup of primary immunodeficiency : daily practice performance in a tertiary university hospital
-
Deciphering the non-coding landscape of pediatric acute myeloid leukemia
-
- Journal Article
- A1
- open access
Targeted therapy in juvenile myelomonocytic leukemia : where are we now?
-
- Conference Paper
- C3
- open access
Deciphering the non-coding landscape of pediatric acute myeloid leukemia
-
- Journal Article
- A1
- open access
Deciphering the non-coding RNA landscape of pediatric acute myeloid leukemia
-
- Journal Article
- A1
- open access
Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies : a EuroFlow study
-
Novel therapeutic targets in juvenile myelomonocytic leukaemia : are noncoding RNAs valuable treatment options?